Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/2003
03/12/2003CN1402710A Antipicornaviral compound and compositions, their pharmaceutical uses, and material for their synthesis
03/12/2003CN1402640A Stabilized liquid polypeptide-confg. pharmaceutical compositions
03/12/2003CN1401390A Immunoregulation medicine-antibody poietins, preparing process and use thereof
03/12/2003CN1401389A Hepatitis B vaccine preparation
03/12/2003CN1401382A Antiviral capsule
03/12/2003CN1401372A Antiinflammatory hemostatic gynecologic medicine and use thereof
03/12/2003CN1401370A Extracted herbal medicine for treating chicken infectious bursa of Fabricius
03/12/2003CN1401369A Antiviral, antibacterial and antiinflammatory herbal injection for treating livestock and fowl infectious disease
03/12/2003CN1401363A External applied medicine for treating hepatitis
03/12/2003CN1401359A Medicine for treating hand and foot tinea and ringworm of nails
03/12/2003CN1401358A Medicine for treating hepatitis, and preparing process thereof
03/12/2003CN1401345A Medicine for treating athlete's foot for external use and producing method thereof
03/12/2003CN1401334A Compound 'Shuanghuanglian' preparation and preparing process thereof
03/12/2003CN1401332A Medicine for treating osteomyelitis and lymphoid tuberculosis, and making process thereof
03/12/2003CN1401328A Epidemic meningitis polyose-protein binding vaccine
03/12/2003CN1401324A Antibiotic medicine for injection
03/12/2003CN1401323A Compound ointment for treating fungous dermatosis
03/12/2003CN1102932C Novel water-soluble analogues of 20(S)-camptothecin, preparing method and use thereof
03/11/2003US6531610 Intermediate acylating carbonate
03/11/2003US6531587 Retrovirus from the HIV group and its use
03/11/2003US6531511 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
03/11/2003US6531508 Antibacterial medicinal compositions
03/11/2003US6531507 Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same
03/11/2003US6531498 Antiallergens, etc
03/11/2003US6531492 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
03/11/2003US6531479 Anti-cancer compounds
03/11/2003US6531476 Piperazine derivatives inhibiting human immunodeficiency virus replication
03/11/2003US6531474 Inhibitors of caspases
03/11/2003US6531470 Oxazolidinone combinatorial libraries, compositions and methods of preparation
03/11/2003US6531465 Antibacterial cephalosporins
03/11/2003US6531452 Peptide-like and peptidomimetic compounds that inhibit enzymatic activity of picornaviral 3C proteases and inhibit picornavirus replication
03/11/2003US6531450 Use treating neuropathological situations caused by the aging of the nervous system; MP52, MP121 are growth or/and differentiation factors of the TGF-beta (transforming growth factor) superfamily
03/11/2003US6531313 Invasive bacterial vectors for expressing alphavirus replicons
03/11/2003US6531276 Using probes to determine duplex formation; use in diagnostic, prophylactic, and therapeutic applications
03/11/2003US6531139 Self-emulsifying formulation for lipophilic compounds
03/11/2003US6531137 Retrovirus from the HIV group and its use
03/11/2003US6531136 Equine rhinovirus 1 proteins
03/11/2003US6531135 Administering to the subject an effective amount of a composition comprising a population of infectious, defective alphavirus particles in a pharmaceutically acceptable carrier
03/11/2003US6531127 Useful for diagnostic purposes for identifying specific antibodies against human papillomavirus 16 E1 or E2 protein, which contains polypeptides with specific amino acid sequece
03/11/2003US6531126 Animal derived lipid
03/11/2003CA2254117C 2,4-diaminopyrimidine derivatives
03/06/2003WO2003019146A2 High throughput screening assays using fatty acid synthetic enzymes
03/06/2003WO2003018820A2 Mutant recombinant adeno-associated viruses related applications
03/06/2003WO2003018817A1 Yeast membrane protein expression system and its application in drug screening
03/06/2003WO2003018811A1 Gene of novel corynebacterium diphtheriae antigen
03/06/2003WO2003018759A2 Phenylalanine ammonia lyase polypeptide and polynucleotide sequences and methods of obtaining and using same
03/06/2003WO2003018745A2 Method of screening for drug hypersensitivity reaction
03/06/2003WO2003018619A2 Antimicrobial and anti-inflammatory peptides
03/06/2003WO2003018617A1 Method of purifying human mannose binding lectin, human mannose binding lectin compositions and medicinal use of human mannose binding lectin
03/06/2003WO2003018615A1 Novel crystal of cyclic lipopeptide compound
03/06/2003WO2003018608A2 Process for purifying glycopeptide phosphonate derivatives
03/06/2003WO2003018607A2 Process for preparing glycopeptide derivatives
03/06/2003WO2003018606A2 Casein derived peptides and uses thereof in therapy
03/06/2003WO2003018602A1 Ferrocene mannose derivatives activating the killing of intracellularly localised microorganisms
03/06/2003WO2003018591A1 Novel pseudolaric acid-b derivatives, their preparation and pharmaceutical compositions
03/06/2003WO2003018582A1 Novel imidazopyridine compounds with therapeutic effect
03/06/2003WO2003018579A1 Alkyne-aryl phosphodiesterase-4 inhibitors
03/06/2003WO2003018576A1 New piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity
03/06/2003WO2003018566A1 New piperidinyl derivates as modulators of chemokine receptor activity
03/06/2003WO2003018556A1 Piperidine derivatives useful as modulators of chemokine receptor activity
03/06/2003WO2003018549A2 Bicyclic compounds as inhibitors of chemokine binding to us28
03/06/2003WO2003018542A1 Novel norstatin derivative
03/06/2003WO2003018537A1 Antiviral protease inhibitors
03/06/2003WO2003018496A1 Antimicrobial, anti-inflammatory, wound-healing glass powder and use thereof
03/06/2003WO2003018495A1 Water-insoluble, antimicrobial silicate glass and use thereof
03/06/2003WO2003018134A2 Bioadhesive compositions and methods for enhanced mucosal drug absorption
03/06/2003WO2003018054A1 Helicobacter pylori vaccination
03/06/2003WO2003018053A1 Vaccine against mycobacterial-induced diseases
03/06/2003WO2003018052A1 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments
03/06/2003WO2003018049A2 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection
03/06/2003WO2003018045A1 A pharmaceutical being used for treating hiv infection, the composition and uses thereof
03/06/2003WO2003018042A1 Compositions for treatment and prevention of cold having antiviral activity
03/06/2003WO2003018031A2 Single dose azithromycin for treating respiratory infections
03/06/2003WO2003018030A1 Mutagenic nucleoside analogs for the treatment of viral disease
03/06/2003WO2003018029A1 Anti-bacterial agents based upon oxoanion binding
03/06/2003WO2003018020A1 Jnk inhibitors
03/06/2003WO2003018017A1 3-substituted 6,7-dihydroxytetrahydroisoquinoline derivatives for use as antibacterial agents
03/06/2003WO2003017996A1 Method for treating pulmonary disease states in mammals by altering indigenous in vivo levels of nitric oxide
03/06/2003WO2003017987A1 Biodegradable polymeric nanocapsules and uses thereof
03/06/2003WO2003017965A1 Oral composition comprising an alkylhydroxybenzoate
03/06/2003WO2003017964A1 Oral composition comprising an alkylhydroxybenzoate
03/06/2003WO2003017963A1 Oral composition comprising an alkylhydroxybenzoate
03/06/2003WO2003017962A1 Oral composition comprising an alkylhydroxybenzoate
03/06/2003WO2003017961A1 Antimicrobial oral composition and method of use
03/06/2003WO2003017960A1 Oral rinse for treatment or prevention of bacterial and fungal infection
03/06/2003WO2003017946A2 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof
03/06/2003WO2003017935A2 Human antibodies specific for interleukin 15 (il-15)
03/06/2003WO2003017924A2 Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
03/06/2003WO2003017769A1 Antimicrobial agent
03/06/2003WO2003002131B1 Strain of micro-organism lactobacillus fermentum me-3 as novel anti-microbial and antioxidative probiotic
03/06/2003WO2002100844A3 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/06/2003WO2002098901A3 Peptide deformylase inhibitors
03/06/2003WO2002096367A3 Targeted multivalent macromolecules
03/06/2003WO2002095036A8 A novel intein and uses thereof
03/06/2003WO2002089780A3 Antiviral compounds
03/06/2003WO2002088178A8 Antigens of group b streptococcus and corresponding dna fragments
03/06/2003WO2002086069A3 Secreted proteins
03/06/2003WO2002085945A3 Vhh single heavy chain antibody and a method for its preparation in a mammal
03/06/2003WO2002085447A3 Microprojection array having a beneficial agent containing coating
03/06/2003WO2002085446A3 Microprojection array immunization patch and method
1 ... 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 ... 1798